|
BECN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.742800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.557200E-01 |
| Normal-vs-Stage2 |
9.324200E-01 |
| Normal-vs-Stage3 |
3.703000E-01 |
| Normal-vs-Stage4 |
1.563160E-01 |
| Stage1-vs-Stage2 |
5.659200E-01 |
| Stage1-vs-Stage3 |
7.810400E-01 |
| Stage1-vs-Stage4 |
5.645200E-01 |
| Stage2-vs-Stage3 |
4.980200E-01 |
| Stage2-vs-Stage4 |
4.044600E-01 |
| Stage3-vs-Stage4 |
6.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.912800E-01 |
| Normal-vs-AfricanAmerican |
5.094400E-01 |
| Normal-vs-Asian |
8.014800E-01 |
| Caucasian-vs-AfricanAmerican |
8.021800E-01 |
| Caucasian-vs-Asian |
8.986600E-01 |
| AfricanAmerican-vs-Asian |
9.654200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.113800E-01 |
| Normal-vs-Female |
2.535600E-01 |
| Male-vs-Female |
1.739580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.912650E-01 |
| Normal-vs-Extreme_Weight |
7.856200E-02 |
| Normal-vs-Obese |
7.659800E-01 |
| Normal-vs-Extreme_Obese |
7.247200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.340200E-01 |
| Normal_Weight-vs-Obese |
3.249600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.716800E-01 |
| Extreme_Weight-vs-Obese |
1.822380E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.313000E-01 |
| Obese-vs-Extreme_Obese |
6.695800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.498600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.650200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.245200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.592480E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.591200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.988000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.667800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.926000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.419700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.376800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.323200E-01 |
| Normal-VS-Type2 PRCC |
3.045400E-01 |
| Normal-VS-KIRP CIMP |
8.838600E-01 |
| Normal-VS-Unclassified PRCC |
8.729400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.822000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.452200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.064800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.065400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.905800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.666800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.739980E-02 |
| Normal-vs-N1 |
9.695600E-01 |
| Normal-vs-N2 |
6.286000E-01 |
| N0-vs-N1 |
8.486400E-02 |
| N0-vs-N2 |
8.553400E-01 |
| N1-vs-N2 |
5.638200E-01 |
|
|
